ArticleDiabetes care1999
Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?
Article in Diabetes care, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02621060 (Effect of the Administration of Chlorogenic Acid on Glucemic Control, Insulin Secretion and Insulin Sensitivity in Patients With Impaired Glucose Tolerance), which is not on this map. Cited by 84 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effect of the Administration of Chlorogenic Acid on Glucemic Control, Insulin Secretion and Insulin Sensitivity in Patients With Impaired Glucose Tolerance
Who cites it
84 citing papers in PubMed, 5 syntheses or guidelines pooled it, 330 citations in OpenAlex.
- Pooled it
- Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.The Cochrane database of systematic reviews · 2018Pooled it
- Lifestyle interventions in preventing new type 2 diabetes in Asian populations.Internal and emergency medicine · 2016Pooled it
- Differences by sex in the prevalence of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance in sub-Saharan Africa: a systematic review and meta-analysis.Bulletin of the World Health Organization · 2013Pooled it
- Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review.BMC public health · 2011Pooled it
- Trial
- Effect of Tang No.1 granule (1) in treating patients with impaired glucose tolerance.Chinese journal of integrative medicine · 2008Trial
- Article
- Prevalence of Prediabetes and Related Modifiable Cardiovascular Risk Factors Among Employees of Ayder Comprehensive Specialized Hospital, Tigray, Northern Ethiopia.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023Article
- A Narrative Review of Human Clinical Trials on the Impact of Phenolic-Rich Plant Extracts on Prediabetes and Its Subgroups.Nutrients · 2021Review
- Association between plasma irisin in pregnancy and postpartum glucose levels among Chinese women: A cohort study.Journal of diabetes investigation · 2021Article
- Predictive capability of fasting-state glucose and insulin measurements for abnormal glucose tolerance in women with polycystic ovary syndrome.Clinical and experimental reproductive medicine · 2021Article
- The role of the gut microbiome and its metabolites in metabolic diseases.Protein & cell · 2021Review
- Article
- Patterns of changes in serum lipid profiles in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients.Lipids in health and disease · 2020Article
- Prevalence of type 2 diabetes mellitus compared between lean and overweight/obese patients with polycystic ovarian syndrome: a 5-year follow-up study.Archives of gynecology and obstetrics · 2020Article
- Factors associated with progression to pre-diabetes: a recurrent events analysis.Eating and weight disorders : EWD · 2020Article
- Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders.International journal of molecular sciences · 2019Review
- Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance test.PloS one · 2019Article
- Differential clusters of modifiable risk factors for impaired fasting glucoseTherapeutic advances in chronic disease · 2019Article
24 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
10 authors at 2 institutions in 3 countries.
Funding
Abstract
objectiveTo determine if impaired fasting glucose (IFG; fasting plasma glucose level 6.1-6.9 mmol/l) can predict future type 2 diabetes as accurately as does impaired glucose tolerance (IGT; 2-h plasma glucose level 7.8-11.0 mmol/l). RESEARCH DESIGN AND
methodsA longitudinal population-based study was performed with surveys in 1987 and 1992 on the island of Mauritius, assessing diabetes status by the oral glucose tolerance test. A total of 3,717 subjects took part in both surveys. Of these subjects, 3,229 were not diabetic in 1987 and formed the basis of this study.
resultsAt baseline, there were 607 subjects with IGT and 266 subjects with IFG. There were 297 subjects who developed diabetes by 1992. For predicting progression to type 2 diabetes, the sensitivity, specificity, and positive predictive values were 26, 94, and 29% for IFG and 50, 84, and 24% for IGT, respectively. Only 26% of subjects that progressed to type 2 diabetes were predicted by their IFG values, but a further 35% could be identified by also considering IGT. The sensitivities were 24% for IFG and 37% for IGT in men and 26% for IFG and 66% for IGT in women, respectively.
conclusionsThese data demonstrate the higher sensitivity of IGT over IFG for predicting progression to type 2 diabetes. Screening by the criteria for IFG alone would identify fewer people who subsequently progress to type 2 diabetes than would the oral glucose tolerance test.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.